Carboplatin/Durvalumab/Pemetrexed Regimen

Preferred Label : Carboplatin/Durvalumab/Pemetrexed Regimen;

NCIt synonyms : Carboplatin/Imfinzi/Alimta; Carboplatin/Pemetrexed/Durvalumab; Durvalumab Plus Carboplatin/Pemetrexed; Carboplatin/Pemetrexed Plus Durvalumab; Carboplatin-Durvalumab-Pemetrexed; Carboplatin/Durvalumab/Pemetrexed; Pemetrexed/Carboplatin Plus Durvalumab;

NCIt definition : A regimen consisting of carboplatin, durvalumab, and pemetrexed that may be used in the treatment of non-small cell lung cancer (NSCLC).;

Détails

Origin ID

C213251;

chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Durvalumab [NCIt concept]
- Pemetrexed Disodium [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients